Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?

Journal of Internal Medicine

Volumn 263, Issue 3, 2008, Pages 294-301

  Suhr, O B ^a   Anan, I ^a   Backman, C ^a   Karlsson, A ^b   Lindqvist, P ^a   Morner S ^a   Waldenstrom A ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloidosis; Brain natriruretic peptide; Cardiomyopathy; Echocardiography; Hereditary; Troponin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I; TROPONIN T;

AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; TERTIARY HEALTH CARE;

ADULT; AGED; AMYLOID; AMYLOID NEUROPATHIES, FAMILIAL; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREALBUMIN; RETROSPECTIVE STUDIES; TROPONIN I; TROPONIN T;

EID: 38849156305     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01888.x     Document Type: Article

References (24)

1. Jacobson DR, Pastore R, Pool S et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996 98 : 236 8.
2. Ranlov I, Alves IL, Ranlov PJ, Husby G, Costa PP, Saraiva MJ. A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers. Am J Med 1992 93 : 3 8.
3. Eriksson P, Karp K, Bjerle P, Olofsson BO. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J 1984 51 : 658 62.
4. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000 6 : 263 76.
5. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997 64 : 74 80.
6. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002 73 : 745 51.
7. Stangou AJ, Hawkins PN, Heaton ND et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998 66 : 229 33.
8. Pomfret EA, Lewis WD, Jenkins RL et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998 65 : 918 25.
9. Suhr OB. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid 2003 10 (Suppl. 1 77 83.
10. Lindqvist P, Olofsson BO, Backman C, Suhr O, Waldenstrom A. Pulsed tissue Doppler and strain imaging discloses early signs of infiltrative cardiac disease: a study on patients with familial amyloidotic polyneuropathy. Eur J Echocardiogr 2006 7 : 22 30.
11. Dispenzieri A, Kyle RA, Gertz MA et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003 361 : 1787 9.
12. Palladini G, Campana C, Klersy C et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003 107 : 2440 5.
13. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002 15 : 167 84.
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978 58 : 1072 83.
15. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983 58 : 665 83.
16. Olofsson BO, Backman C, Boman K. Familial amyloidotic polyneuropathy in northern Sweden. A cross- sectional and longitudinal study of cardiac function with echocardiography. Arctic Med Res 1988 47 (Suppl. 1 423 5.
17. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005 165 : 1425 9.
18. Nordlinger M, Magnani B, Skinner M, Falk RH. Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol 2005 96 : 982 4.
19. Engstrom I, Ronquist G, Pettersson L, Waldenstrom A. Alzheimer amyloid beta-peptides exhibit ionophore-like properties in human erythrocytes. Eur J Clin Invest 1995 25 : 471 6.
20. Brenner DA, Jain M, Pimentel DR et al. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 2004 94 : 1008 10.
21. Peng X, Kim E, Miller T et al. Human amyloidogenic light chains alter cardiomyocyte signaling through disruption of heparin sulfate proteoglycan (HSPG) complex. Amyloid 2006 13 (Suppl. 1) : p 2 (abstr).
22. Suhr OB, Lindqvist P, Olofsson B-O, Waldenström A, Backman C. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid 2006 13 : 154 9.
23. Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid 2003 10 : 229 39.
24. Koike H, Misu K, Sugiura M et al. Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 2004 63 : 129 38.